April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Macular Pigment Optical Density, Lipoproteins, and Docosahexaenoic Acid in Age-Related Macular Degeneration Patients and Age Matched Controls
Author Affiliations & Notes
  • S. T. Bailey
    Ophthalmology, Casey Eye Institute, OHSU, Portland, Oregon
  • M. L. Klein
    Ophthalmology, Casey Eye Institute, OHSU, Portland, Oregon
  • S. L. Connor
    Medicine/Clinical Nutrition, OHSU, Portland, Oregon
  • W. E. Connor
    Medicine/Clinical Nutrition, OHSU, Portland, Oregon
  • Footnotes
    Commercial Relationships  S.T. Bailey, None; M.L. Klein, None; S.L. Connor, None; W.E. Connor, None.
  • Footnotes
    Support  Foundation for Fighting Blindness RPF-691
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 239. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. T. Bailey, M. L. Klein, S. L. Connor, W. E. Connor; Macular Pigment Optical Density, Lipoproteins, and Docosahexaenoic Acid in Age-Related Macular Degeneration Patients and Age Matched Controls. Invest. Ophthalmol. Vis. Sci. 2009;50(13):239.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare macular pigment optical density (MPOD) in the fellow eye of individuals with unilateral advanced age-related macular degeneration (AMD) with eyes of individuals with no AMD; and to evaluate the dietary and plasma levels of lutein/zeaxanthin, lipoprotein, and docosahexaenoic acid (DHA) profile in these two cohorts.

Methods: : Patients selected in the AMD group had advanced AMD (choroidal neovascularization or geographic atrophy) in one eye and large drusen with visual acuity 20/40 or better in the fellow eye (study eye). Heterochromatic flicker photometry (HFP), using a standardized protocol, was performed to determine the MPOD in the study eye of the AMD group as well as a control group consisting of one eye (randomly selected) of age matched individuals with no AMD (less than 5 small drusen no larger than 63 microns in diameter). Both groups completed detailed food frequency questionnaires and any individual taking greater than 275 micrograms of lutein supplements was excluded. Dietary levels and plasma levels of lutein/zeaxanthin, lipoproteins, and DHA in the AMD group and controls were compared.

Results: : MPOD results were obtained for 19 eyes of 19 individuals in the AMD group, and 21 eyes of 21 individuals in the control group. Individuals in the AMD group had a slightly higher mean MPOD level (0.457) than those in the control group (0.418). The difference was not statistically significant (p=0.5413). There were no statistically significant differences between the AMD group and the control group with regard to dietary and plasma levels of lutein/zeaxanthin, lipoproteins, and DHA.

Conclusions: : Eyes with AMD did not demonstrate a deficiency of lutein and zeaxanthin in the macula compared to age matched controls. No differences were detected in dietary and plasma levels of lutein/zeaxanthin, lipoproteins and DHA.

Keywords: age-related macular degeneration • carotenoids/carotenoid binding proteins • macular pigment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×